State Street’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $88.9K | Hold |
42,960
| – | – | ﹤0.01% | 3998 |
|
2025
Q1 | $72.2K | Hold |
42,960
| – | – | ﹤0.01% | 4032 |
|
2024
Q4 | $94.5K | Hold |
42,960
| – | – | ﹤0.01% | 3998 |
|
2024
Q3 | $64K | Hold |
42,960
| – | – | ﹤0.01% | 4056 |
|
2024
Q2 | $85.1K | Hold |
42,960
| – | – | ﹤0.01% | 4046 |
|
2024
Q1 | $132K | Hold |
42,960
| – | – | ﹤0.01% | 3973 |
|
2023
Q4 | $297K | Hold |
42,960
| – | – | ﹤0.01% | 3784 |
|
2023
Q3 | $147K | Hold |
42,960
| – | – | ﹤0.01% | 4011 |
|
2023
Q2 | $116K | Hold |
42,960
| – | – | ﹤0.01% | 4198 |
|
2023
Q1 | $78.2K | Hold |
42,960
| – | – | ﹤0.01% | 4393 |
|
2022
Q4 | $98.4K | Hold |
42,960
| – | – | ﹤0.01% | 4374 |
|
2022
Q3 | $58K | Buy |
42,960
+4,400
| +11% | +$5.94K | ﹤0.01% | 4624 |
|
2022
Q2 | $100K | Buy |
+38,560
| New | +$100K | ﹤0.01% | 4537 |
|